The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Anemia
Open accessAbstract
CONTEXT: Sickle cell anemia (SCA) is a chronic illness causing progressive deterioration in quality of life. Brain dysfunction may be the most important and least studied problem affecting individuals with this disease. OBJECTIVE: To measure neurocognitive dysfunction in neurologically asymptomatic adults with SCA vs healthy control individuals. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study comparing neuropsychological function and neuroimaging findings in neurologically asymptomatic adults with SCA and controls from 12 SCA centers, conducted between December 2004 and May 2008. Participants were patients with SCA (hemoglobin [Hb] SS and hemoglobin level < or = 10 mg/dL) aged 19 to 55 years and of African descent (n = 149) or community controls (Hb AA and normal hemoglobin level) (n = 47). Participants were stratified on age, sex, and education. MAIN OUTCOME MEASURES: The primary outcome measure was nonverbal function assessed by the Wechsler Adult Intelligence Scale, third edition (WAIS-III) Performance IQ Index. Secondary exploratory outcomes included performance on neurocognitive tests of executive function, memory, attention, and language and magnetic resonance imaging measurement of total intracranial and hippocampal volume, cortical gray and white matter, and lacunae. RESULTS: The mean WAIS-III Performance IQ score of patients with SCA was significantly lower than that of controls (adjusted mean, 86.69 for patients with SCA vs 95.19 for controls [mean difference, -5.50; 95% confidence interval {CI}, -9.55 to -1.44]; P = .008), with 33% performing more than 1 SD (<85) below the population mean. Among secondary measures, differences were observed in adjusted mean values for global cognitive function (full-scale IQ) (90.47 for patients with SCA vs 95.66 for controls [mean difference, -5.19; 95% CI, -9.24 to -1.13]; P = .01), working memory (90.75 vs 95.25 [mean difference, -4.50; 95% CI, -8.55 to -0.45]; P = .03), processing speed (86.50 vs 97.95 [mean difference, -11.46; 95% CI, -15.51 to -7.40]; P < .001), and measures of executive function. Anemia was associated with poorer neurocognitive function in older patients. No differences in total gray matter or hippocampal volume were observed. Lacunae were more frequent in patients with SCA but not independently related to neurocognitive function. CONCLUSION: Compared with healthy controls, adults with SCA had poorer cognitive performance, which was associated with anemia and age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The largest study to date of cognitive function in adults with SCD has shown that 33% of a cohort of patients with homozygous SCD and without severe complications performed 1 standard deviation worse than the population mean in cognitive tests and had a much higher prevalence of lacunar infarcts (13% versus 2%).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [178]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, there was no association between lacunae and cognitive function (178).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [178]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 3×
“The major findings are that (1) adults with SCA showed poorer performance on neurocognitive tests when compared with community controls; (2) anemia is associated with the age-related decline in cognitive performance; and (3) MRI findings do not explain the performance differences in the subset of patients with neuroim…”
Abraham, J. M. (2010) · Brill | Nijhoff eBooks · doi:10.1163/ej.9789004163300.i-1081.897 · Cited by 2,612
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Outcome of Sickle Cell Anemia: A 4-Decade Observational Study of 1056 Patients
Powars, D. R., Chan, L. S., Hiti, A., Ramicone, E., & Johnson, C. (2005) · Medicine · doi:10.1097/01.md.0000189089.45003.52 · Cited by 558
ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice.
Bhuiyan, P. S., & Rege, N. N. (2001) · PubMed · Cited by 527
Flagged first, then by citations
2 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 296
Rigano, P., Pecoraro, A., Calvaruso, G., Steinberg, M. H., Iannello, S., & Maggio, A. (2013) · American Journal of Hematology · doi:10.1002/ajh.23531 · Cited by 23
Defining the Phenotypes of Sickle Cell Disease
Ballas, S. K. (2011) · Hemoglobin · doi:10.3109/03630269.2011.610477 · Cited by 23
El-Alameey, I. R., Alzaree, F. A., Shehata, M. A., Shady, M. M. A., Atti, M. A., & El‐Khonezy, M. I. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.077 · Cited by 22
Crosby, L. E., Joffe, N. E., Reynolds, N. C., Peugh, J., Manegold, E. M., & Pai, A. L. H. (2015) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsv073 · Cited by 22
Crawford, R. D., & Jonassaint, C. R. (2015) · Journal of Advanced Nursing · doi:10.1111/jan.12755 · Cited by 22
Risk Factors for Attention and Behavioral Issues in Pediatric Sickle Cell Disease
Lance, E. I., Comi, A. M., Johnston, M. V., Casella, J. F., & Shapiro, B. K. (2015) · Clinical Pediatrics · doi:10.1177/0009922815594356 · Cited by 22
Cerebral hemodynamic assessment and neuroimaging across the lifespan in sickle cell disease
Jordan, L. C., & DeBaun, M. R. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17701763 · Cited by 22
Performance validity testing in a clinical sample of adults with sickle cell disease
Dorociak, K. E., Schulze, E. T., Piper, L. E., Molokie, R. E., & Janecek, J. K. (2017) · The Clinical Neuropsychologist · doi:10.1080/13854046.2017.1339830 · Cited by 21
Academic Challenges and School Service Utilization in Children with Sickle Cell Disease
Karkoska, K. A., Haber, K., Elam, M. P., Strong, S., & McGann, P. T. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.11.062 · Cited by 21
Neurocognitive functioning in preschool children with sickle cell disease
Heitzer, A. M., Cohen, D. L., Okhomina, V. I., Trpchevska, A., Potter, B., Longoria, J. N., Porter, J. S., Estepp, J. H., King, A. A., Henley, M., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29531 · Cited by 22
Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease
Ansari, J., Moufarrej, Y. E., Pawliński, R., & Gavins, F. N. E. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2018.1407240 · Cited by 24
Silent cerebral infarct definitions and full-scale IQ loss in children with sickle cell anemia
Choudhury, N. A., DeBaun, M. R., Rodeghier, M., King, A. A., Strouse, J. J., & McKinstry, R. C. (2017) · Neurology · doi:10.1212/wnl.0000000000004832 · Cited by 21
Martin, S. C., Roderick, M. C., Abel, C., Wolters, P. L., Toledo‐Tamula, M. A., Fitzhugh, C. D., Hsieh, M. M., & Tisdale, J. F. (2019) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2019.1598876 · Cited by 21
Early, M. L., Strodel, R. J., Lake, I. V., Ruddy, J. A., Saba, J. A., Singh, S. M., Lanzkron, S., Mack, J. W., Meier, E. R., Christianson, M. S., et al. (2021) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-021-02358-z · Cited by 20
Role of age and neuroinflammation in the mechanism of cognitive deficits in sickle cell disease
Hardy, R. A., Rached, N. A., Jones, J. A., Archer, D. R., & Hyacinth, H. I. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220958011 · Cited by 23
Neurologic complications of sickle cell disease
Venkataraman, A., & Adams, R. J. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4087-0.00068-1 · Cited by 19
Crosby, L. E., Joffe, N. E., Davis, B., Quinn, C. T., Shook, L. M., Morgan, D., Simmons, K., & Kalinyak, K. A. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.01.021 · Cited by 19
Functional Connectivity Decreases with Metabolic Stress in Sickle Cell Disease
Fields, M. E., Mirro, A. E., Guilliams, K. P., Binkley, M. M., Diaz, L. G., Tan, J. J., Fellah, S., Eldeniz, C., Chen, Y., Ford, A. L., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25891 · Cited by 19
Janecek, J. K., Dorociak, K. E., Piper, L. E., Kelleher, T., Pliskin, N. H., Gowhari, M., & Molokie, R. E. (2018) · The Clinical Neuropsychologist · doi:10.1080/13854046.2018.1535664 · Cited by 18
Pediatric Sickle Cell Disease and Stroke: A Literature Review
Parikh, T., Goti, A. M., Yashi, K., Ravikumar, N. P. G., Parmar, N. G., Dankhara, N., & Satodiya, V. (2023) · Cureus · doi:10.7759/cureus.34003 · Cited by 18
Howard, J., Slee, A. E., Skene, S. S., Inusa, B. P. D., Kawadler, J. M., Downes, M., Gavlak, J., Kölbel, M., Stotesbury, H., Chorozoglou, M., et al. (2018) · Trials · doi:10.1186/s13063-017-2419-0 · Cited by 18
Early, M. L., Linton, E., Bosch, A., Campbell, T., Hill‐Briggs, F., Pecker, L. H., Lance, E. I., & Lanzkron, S. (2022) · British Journal of Haematology · doi:10.1111/bjh.18188 · Cited by 16
Cichowitz, C., Carroll, P. C., Strouse, J. J., Haywood, C., & Lanzkron, S. (2016) · Southern Medical Journal · doi:10.14423/smj.0000000000000511 · Cited by 17
Quality of life, mood disorders, and cognitive impairment in adults with β-thalassemia
Bizri, M., Koleilat, R., Akiki, N., Dergham, R., Mihailescu, A. M., Bou‐Fakhredin, R., Musallam, K. M., & Taher, A. T. (2024) · Blood Reviews · doi:10.1016/j.blre.2024.101181 · Cited by 17
Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease
Jones, R. S., Ford, A. L., Donahue, M. J., Fellah, S., Davis, L. T., Pruthi, S., Balamurugan, C., Cohen, R., Davis, S. M., DeBaun, M. R., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209247 · Cited by 17
Rodgers‐Melnick, S. N., Pell, T. J. G., Lane, D., Jenerette, C. M., Fu, P., Margevicius, S. P., & Little, J. A. (2017) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2017-0004 · Cited by 17
Disease severity and slower psychomotor speed in adults with sickle cell disease
Jorgensen, D. R., Metti, A. L., Butters, M. A., Mettenburg, J., Rosano, C., & Novelli, E. M. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017008219 · Cited by 17
Bernaudin, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101523 · Cited by 18
White, K. P., Østbye, T., Harth, M., Nielson, W. R., Speechley, M. R., Teasell, R. W., & Bourne, R. B. (2000) · PubMed · Cited by 17
Downes, M., Kirkham, F. J., Telfer, P. T., & de Haan, M. D. H. (2017) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsx115 · Cited by 17
How do I transfuse patients with sickle cell disease?
Quirolo, K. C. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02774.x · Cited by 16
Applying a Developmental–Ecological Framework to Sickle Cell Disease Transition
Griffin, A. T., Gilleland, J., Johnson, A. Q., Cummings, L., New, T. N., Brailey, T., Eckman, J., & Osunkwo, I. (2013) · Clinical Practice in Pediatric Psychology · doi:10.1037/cpp0000027 · Cited by 16
Patient-centered Approach to Designing Sickle Cell Transition Education
Williams, C., Smith, C. H., Osborn, K., Bemrich‐Stolz, C. J., Hilliard, L., Howard, T. H., & Lebensburger, J. D. (2014) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000169 · Cited by 16
Neurocognitive Complications of Sickle Cell Anemia in Adults
Ballas, S. K. (2010) · JAMA · doi:10.1001/jama.2010.610 · Cited by 16
An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model
Treadwell, M. J., Mushiana, S., Badawy, S. M., Preiss, L., King, A. A., Kroner, B. L., Chen, Y., Glassberg, J., Gordeuk, V. R., Shah, N., et al. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03132-z · Cited by 15
Costa, T. C. D. M., Correia, R. D. C., Salmón, C. E. G., Darrigo, L. G., Grecco, C. E. S., Pieroni, F., Faria, J. T. B., Stracieri, A. B. P. L., Dias, J. B. E., Moraes, D. A., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01365-z · Cited by 15
Improving Outcomes in Children with Sickle Cell Disease: Treatment Considerations and Strategies
Amid, A., & Odame, I. (2014) · Pediatric Drugs · doi:10.1007/s40272-014-0074-4 · Cited by 15
Neurovascular Manifestations of Sickle Cell Disease
Zedde, M., Quaresima, M., Capodanno, I., Grisendi, I., Assenza, F., Napoli, M., Moratti, C., Pavone, C., Bonacini, L., Cecco, G. D., et al. (2024) · Hemato · doi:10.3390/hemato5030023 · Cited by 14
Marinho, C. D. L., Maioli, M. C. P., Amaral, J. L. M., Lopes, A. J., & de Melo, P. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213257 · Cited by 14
Silva, J. T. D., Letzen, J. E., Haythornthwaite, J. A., Finan, P. H., Campbell, C. M., & Seminowicz, D. A. (2019) · Pain · doi:10.1097/j.pain.0000000000001591 · Cited by 15
Forté, S., Blais, F., Castonguay, M., Fadiga, N., Fortier-St-Pierre, M., Couette, M., Ward, R. A., Béland, S., Cohn, M., Soulières, D., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.7039 · Cited by 14
Sleep Quality, Pain and Self-Efficacy among Community-Dwelling Adults with Sickle Cell Disease.
Adegbola, M. (2015) · PubMed · Cited by 14
Assessment of Executive Functions in Preschool Children With Sickle Cell Anemia
Downes, M., Kirkham, F. J., Telfer, P. T., & de Haan, M. D. H. (2018) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617718000255 · Cited by 14
The Sickle Cell Disease Functional Assessment (SCD-FA) tool: a feasibility pilot study
Oyedeji, C. I., Hall, K. S. M., Luciano, A., Morey, M. C., & Strouse, J. J. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01005-3 · Cited by 17
Solomou, E., Kraniotis, P., Kourakli, A., & Petsas, T. G. (2013) · Hematology Reports · doi:10.4081/hr.2013.e3 · Cited by 13
Jorgensen, D. R., Rosano, C., & Novelli, E. M. (2016) · Hemoglobin · doi:10.1080/03630269.2016.1242493 · Cited by 13
Stotesbury, H., Kawadler, J. M., Clayden, J. D., Saunders, D. E., Hood, A., Kölbel, M., Sahota, S. K., Rees, D. C., Wilkey, O., Layton, M., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.867329 · Cited by 13
Clinical Manifestations of Sickle Cell Disease Across the Lifespan
Pecker, L. H., & Little, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-62328-3_1 · Cited by 14
Meier, E. R., Abraham, A., Ngwube, A. I., Janson, I. A., Guilcher, G. M. T., Horan, J., & Kasow, K. A. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.28861 · Cited by 13
Neurocognitive Testing and Functioning in Adults Sickle Cell Disease
Feliu, M., Crawford, R. D., Edwards, L., Wellington, C. C., Wood, M. E., Whitfield, K. E., & Edwards, C. L. (2011) · Hemoglobin · doi:10.3109/03630269.2011.626098 · Cited by 13
Thalassemia Major and Sickle Cell Disease in Adolescents and Young Adults
Yacobovich, J., & Tamary, H. (2014) · Acta Haematologica · doi:10.1159/000360235 · Cited by 12
Jones, K. E., Nyman, T., Daly, B. P., Jacobson, L. A., & Tarazi, R. A. (2021) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsab094 · Cited by 12
Cognitive Function in Adults with Beta-Thalassemia Major in Oman: A Pilot Study
Daar, S., Saadoon, M. A., Wali, Y. A. M. S., Al-Mujaini, R., Rahbi, S. A., Chan, M. F., Al-Siyabi, A., Alansary, N., Mahadevan, S. K., & Al‐Adawi, S. (2021) · Oman Medical Journal · doi:10.5001/omj.2021.101 · Cited by 12
Ampomah, M. A., Drake, J. A., Anum, A., Amponsah, B., Dei‐Adomakoh, Y., Anie, K. A., Mate-Kole, C. C., Jonassaint, C. R., & Kirkham, F. J. (2022) · British Journal of Haematology · doi:10.1111/bjh.18386 · Cited by 12
Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell disease
Quinn, C. T. (2014) · Hematology · doi:10.1182/asheducation-2014.1.438 · Cited by 12
Clinical Manifestations and Treatment of Adult Sickle Cell Disease
Costa, F. F., & Fertrin, K. Y. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_12 · Cited by 12
Kelly, S., Rodeghier, M., & DeBaun, M. R. (2020) · Transfusion · doi:10.1111/trf.15982 · Cited by 12
Downes, M., Keenan, L., Duane, Y., Duffy, K., Fortune, G. M., Geoghegan, R., Conroy, H., & McMahon, C. (2020) · The Clinical Neuropsychologist · doi:10.1080/13854046.2020.1847325 · Cited by 13
Maduakor, C., Alakbarzade, V., Sammaraiee, Y., Vakrinou, A., Corobana, A., Sikorska, J., Rhodes, E., & Pereira, A. C. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.744118 · Cited by 12
End Organ Affection in Sickle Cell Disease
Bathla, T., Lotfollahzadeh, S., Quisel, M. J., Mehta, M., Malikova, M. A., & Chitalia, V. C. (2024) · Cells · doi:10.3390/cells13110934 · Cited by 11
The five key things you need to know to manage adult patients with sickle cell disease
Lanzkron, S., & Haywood, C. (2015) · Hematology · doi:10.1182/asheducation-2015.1.420 · Cited by 11
Chai, Y., Ji, C., Coloigner, J., Choi, S., Balderrama, M., Vu, C. Q., Tamrazi, B., Coates, T. D., Wood, J. C., O’Neil, S., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.1978 · Cited by 11
Portela, G., Butters, M. A., Brooks, M. M., Candra, L., Rosano, C., & Novelli, E. M. (2022) · American Journal of Hematology · doi:10.1002/ajh.26643 · Cited by 11
Early Strokes Are Associated with More Global Cognitive Deficits in Adults with Sickle Cell Disease
Couette, M., Forté, S., Doglioni, D. O., Dessap, A. M., Calvet, D., Kuo, K. H. M., & Bartolucci, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041615 · Cited by 11
Vasculopathie cérébrale de l’enfant drépanocytaire : points clés et nouveautés
Corvest, V., Blais, S., Dahmani, B., de Tersant, M., Etienney, A.-C., Maroni, A., Ormières, C., Roussel, A. M., & Pondarré, C. (2017) · Archives de Pédiatrie · doi:10.1016/j.arcped.2017.11.015 · Cited by 11
More Blood for Sickle Cell Anemia?
Steinberg, M. H. (2014) · New England Journal of Medicine · doi:10.1056/nejme1405776 · Cited by 11
Brain Age Modeling and Cognitive Outcomes in Young Adults With and Without Sickle Cell Anemia
Ford, A. L., Fellah, S., Wang, Y., Unger-Levinson, K., Hagan, M., Reis, M. N., Mirro, A. E., Lewis, J. B., Ying, C., Guilliams, K. P., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.53669 · Cited by 10
Sickle cell disease mice have cerebral oxidative stress and vascular and white matter abnormalities
Khaibullina, A., Almeida, L. E. F., Kamimura, S., Zerfas, P. M., Smith, M. L., Vogel, S., Wakim, P., Vasconcelos, O. M., Quezado, M., Horkayne‐Szakaly, I., et al. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102493 · Cited by 11
Raz, S., Koren, A., & Levin, C. (2019) · British Journal of Haematology · doi:10.1111/bjh.15957 · Cited by 10
Apollonsky, N., Lerner, N. B., Zhang, F., Raybagkar, D. A., Eng, J., & Tarazi, R. A. (2020) · Advances in Hematology · doi:10.1155/2020/8181425 · Cited by 10
Jacob, M., Stotesbury, H., Kija, E., Saunders, D. E., Mtei, R. J., Tutuba, H. J., Masamu, U., Kilonzo, M. N., Kazema, R., Hood, A., et al. (2022) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2022.01.010 · Cited by 10
Adhesion molecules and cerebral microvascular hemodynamic abnormalities in sickle cell disease
Rached, N. A., Gbotosho, O. T., Archer, D. R., Jones, J. A., Sterling, M. S., & Hyacinth, H. I. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.976063 · Cited by 10
Helton, K. J., Glass, J. O., Reddick, W. E., Paydar, A., Zandieh, A. R., Dave, R., Smeltzer, M. P., Wu, S., Hankins, J. S., Aygün, B., et al. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24559 · Cited by 9
Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohort
Cahill, C. R., Leach, J. M., McClure, L. A., Irvin, M. R., Zakai, N. A., Naik, R. P. P., Unverzagt, F. W., Wadley, V. G., Hyacinth, H. I., Manly, J. J., et al. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.05.003 · Cited by 9
Hidden brain iron content in sickle cell disease: impact on neurocognitive functions
Elalfy, M. S., Ibrahim, A. S., Ibrahim, G. S., Hussein, H. M. A. G., Mohammed, H. G. E., & Ebeid, F. S. E. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-04189-7 · Cited by 9
Bhatt, R. R., Zeltzer, L. K., Coloigner, J., Wood, J. C., Coates, T. D., & Labus, J. S. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101686 · Cited by 9
Messimeris, D., Bismuth, H., Provost, C., Emaer, C., Mêlé, N., Kitenge, R., Arlet, J., Joseph, L., Ranque, B., Bartolucci, P., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023010925 · Cited by 8
Power, L. C., Mirro, A. E., Binkley, M. M., Wang, J., Guilliams, K. P., Lewis, J. B., Ford, A. L., Shimony, J. S., An, H., Lee, J., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209429 · Cited by 8
Moss, H. E., Oltra, E., Chow, C., Wubben, T. J., Lim, J., & Chau, F. Y. (2015) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.150632 · Cited by 7
Almeida, L. E. F., Wang, L., Kamimura, S., Zerfas, P. M., Smith, M. L., Neto, O. L. A., Vale, T., Quezado, M., Horkayne‐Szakaly, I., Wakim, P., et al. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146968 · Cited by 8
Kringle, E. A., Novelli, E. M., Butters, M. A., & Skidmore, E. R. (2022) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617722000406 · Cited by 8
Magnetic resonance imaging in pediatric sickle cell anemia
Zhang, X., Li, C., & Li, Q. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3417 · Cited by 7
Access to hematopoietic stem cell transplant for patients with sickle cell anemia
Meier, E. R., Johnson, T. S., Pinkney, K. A., Velez, M. C., Kamani, N. R., & Odame, I. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27105 · Cited by 7
The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia
Amlie‐Lefond, C., Flanagan, J. M., Kanter, J., & Dobyns, W. B. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.06.004 · Cited by 7
Oyedeji, C. I., Hall, K. S. M., Luciano, A., Morey, M. C., & Strouse, J. J. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00673-3 · Cited by 9
Developmental screening of three‐year‐old children with sickle cell disease compared to controls
Wang, W. C., Freeman, M., Hamilton, L., Carroll, Y. M., Kang, G., Moen, J., Smeltzer, M. P., Schreiber, J. E., Heitzer, A. M., Estepp, J. H., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17780 · Cited by 7
Longoria, J. N., Howell, K. E., Porter, J. S., Treadwell, M. J., King, A. A., Gordeuk, V. R., Shah, N., Abrams, C. M., McCuskee, S., Gollan, S., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19881 · Cited by 6
Naggayi, S. K., Kalibbala, D., Mboizi, V., Ssenkusu, J. M., Jin, Z., Rosano, C., Munube, D., Wambaka, B., Namazzi, R., Kasirye, P., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015073 · Cited by 7
Chen, Y., Wang, Y., Phuah, C., Fields, M. E., Guilliams, K. P., Fellah, S., Reis, M. N., Binkley, M. M., An, H., Lee, J., et al. (2023) · Stroke · doi:10.1161/strokeaha.123.042683 · Cited by 6
Couette, M., Roy, J., Doglioni, D. O., Bereznyakova, O., Stapf, C., Jacquin, G., Fraïle, V., Desmarais, P., Desforges, S.-M., Touma, L., et al. (2023) · La Presse Médicale · doi:10.1016/j.lpm.2023.104207 · Cited by 6
Imaging review of sickle cell disease for the emergency radiologist
Gilyard, S. N., Hamlin, S. L., Johnson, J.-O., & Herr, K. D. (2020) · Emergency Radiology · doi:10.1007/s10140-020-01828-8 · Cited by 6
Ojinnaka, U., Ahmed, Z., Kannan, A., Quadir, H., Hakobyan, K., Gaddam, M., & Mostafa, J. A. (2021) · Cureus · doi:10.7759/cureus.18906 · Cited by 6
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease
Ramos, K. N., Guilliams, K. P., & Fields, M. E. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.07.011 · Cited by 6
Sickle‐cell disease and compromised cognition
Wang, W. C. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23000 · Cited by 6
A Comparison of Intelligence Quotient in Children with and without β-Thalassemia Major
Meymandi, S. H., Seyednezhad-Golkhatmi, S. H., & Meymandi, M. H. (2015) · Galen Medical Journal · doi:10.31661/gmj.v4i4.374 · Cited by 6
Jonassaint, C. R., Birenboim, A., Jorgensen, D. R., Novelli, E. M., & Rosso, A. L. (2017) · British Journal of Haematology · doi:10.1111/bjh.14598 · Cited by 6
Chen, N., Caruso, C. M., Alonso, Á., Derebail, V. K., Kshirsagar, A. V., Sharrett, A. R., Key, N. S., Gottesman, R. F., Grove, M. L., Bressler, J., et al. (2019) · eNeurologicalSci · doi:10.1016/j.ensci.2019.100201 · Cited by 6
Effects of regional brain volumes on cognition in sickle cell anemia: A developmental perspective
Hamdule, S., Kölbel, M., Stotesbury, H., Murdoch, R., Clayden, J. D., Sahota, S. K., Hood, A., Clark, C. A., & Kirkham, F. J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1101223 · Cited by 8
Krishnamurti, L. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2019.12.008 · Cited by 5
Academic performance in Jamaican children with sickle cell disease
King, L. G., Ali, S. B., Chang-Lopez, S. M., Reid, M. E., & Soares, D. (2023) · Journal of the National Medical Association · doi:10.1016/j.jnma.2023.07.005 · Cited by 5
Metadata
- Authors
- Vichinsky, E. P.
- Affiliations
- UCSF Benioff Children's Hospital (US)
- Corresponding author
- Vichinsky, Elliott P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-05-12
- Volume
- 303
- Issue
- 18
- Pages
- 1823
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC2892214
- OpenAlex
- W2132032699
- Cited by
- 296
- References
- 43
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 19 · 2023: 18 · 2022: 20 · 2021: 22 · 2020: 28 · 2019: 19 · 2018: 15 · 2017: 19 · 2016: 20 · 2015: 16 · 2014: 19 · 2013: 20 · 2012: 14
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U54HL070583, U54HL070587)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- sickle cell disease, neurocognitive impairment, nonverbal intelligence, performance IQ, working memory, processing speed, executive function, hippocampal volume, intracranial volume, white matter, lacunae, neuroimaging abnormalities, African Americans, hemoglobin SS, hemoglobin levels, language functions
- MeSH terms
- Adult, Age Factors, Anemia, Anemia, Sickle Cell, Brain, Hypoxia, Brain, Cognition Disorders, Cross-Sectional Studies, Female, Humans, Intelligence Tests, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
